These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 30374196)

  • 1. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.
    Sepulcre J; Grothe MJ; d'Oleire Uquillas F; Ortiz-Terán L; Diez I; Yang HS; Jacobs HIL; Hanseeuw BJ; Li Q; El-Fakhri G; Sperling RA; Johnson KA
    Nat Med; 2018 Dec; 24(12):1910-1918. PubMed ID: 30374196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology.
    Grothe MJ; Sepulcre J; Gonzalez-Escamilla G; Jelistratova I; Schöll M; Hansson O; Teipel SJ;
    Brain; 2018 Sep; 141(9):2755-2771. PubMed ID: 30016411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
    Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
    Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex.
    Sepulcre J; Grothe MJ; Sabuncu M; Chhatwal J; Schultz AP; Hanseeuw B; El Fakhri G; Sperling R; Johnson KA
    JAMA Neurol; 2017 Jul; 74(7):813-820. PubMed ID: 28558094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transmission of pathogenic protein aggregates in Alzheimer's disease].
    Schwarzman AL; Sarantseva SV
    Mol Biol (Mosk); 2017; 51(3):418-422. PubMed ID: 28707657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOEε4 potentiates amyloid β effects on longitudinal tau pathology.
    Ferrari-Souza JP; Bellaver B; Ferreira PCL; Benedet AL; Povala G; Lussier FZ; Leffa DT; Therriault J; Tissot C; Soares C; Wang YT; Chamoun M; Servaes S; Macedo AC; Vermeiren M; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Cohen A; Lopez OL; Klunk WE; Soucy JP; Gauthier S; Souza DO; Triana-Baltzer G; Saad ZS; Kolb HC; Karikari TK; Villemagne VL; Tudorascu DL; Ashton NJ; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Nat Aging; 2023 Oct; 3(10):1210-1218. PubMed ID: 37749258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal Degeneration and Alzheimer's Disease: An Evolving Link.
    Ashok A; Singh N; Chaudhary S; Bellamkonda V; Kritikos AE; Wise AS; Rana N; McDonald D; Ayyagari R
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.
    Villemagne VL; Doré V; Burnham SC; Masters CL; Rowe CC
    Nat Rev Neurol; 2018 Apr; 14(4):225-236. PubMed ID: 29449700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.
    Nägga K; Gustavsson AM; Stomrud E; Lindqvist D; van Westen D; Blennow K; Zetterberg H; Melander O; Hansson O
    Neurology; 2018 Jan; 90(1):e73-e81. PubMed ID: 29196581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer's disease.
    Freer R; Sormanni P; Vecchi G; Ciryam P; Dobson CM; Vendruscolo M
    Sci Adv; 2016 Aug; 2(8):e1600947. PubMed ID: 27532054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum.
    Cho H; Lee HS; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2018 Aug; 68():76-84. PubMed ID: 29751288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.
    Brier MR; Gordon B; Friedrichsen K; McCarthy J; Stern A; Christensen J; Owen C; Aldea P; Su Y; Hassenstab J; Cairns NJ; Holtzman DM; Fagan AM; Morris JC; Benzinger TL; Ances BM
    Sci Transl Med; 2016 May; 8(338):338ra66. PubMed ID: 27169802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial activation and tau propagate jointly across Braak stages.
    Pascoal TA; Benedet AL; Ashton NJ; Kang MS; Therriault J; Chamoun M; Savard M; Lussier FZ; Tissot C; Karikari TK; Ottoy J; Mathotaarachchi S; Stevenson J; Massarweh G; Schöll M; de Leon MJ; Soucy JP; Edison P; Blennow K; Zetterberg H; Gauthier S; Rosa-Neto P
    Nat Med; 2021 Sep; 27(9):1592-1599. PubMed ID: 34446931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.
    Ciccone L; Shi C; di Lorenzo D; Van Baelen AC; Tonali N
    Molecules; 2020 May; 25(10):. PubMed ID: 32456156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.
    Sintini I; Graff-Radford J; Jones DT; Botha H; Martin PR; Machulda MM; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Cereb Cortex; 2021 Feb; 31(3):1693-1706. PubMed ID: 33152765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.